These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17204908)

  • 1. Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
    Heringer-Walther S; Moreira Mda C; Wessel N; Wang Y; Ventura TM; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):293-8. PubMed ID: 17204908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation.
    Moreira Mda C; Heringer-Walther S; Wessel N; Moreira Ventura T; Wang Y; Schultheiss HP; Walther T
    Cardiology; 2008; 110(4):217-25. PubMed ID: 18073475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides.
    Moreira Mda C; Wang Y; Heringer-Walther S; Wessel N; Walther T
    Congest Heart Fail; 2009; 15(2):75-81. PubMed ID: 19379453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino-terminal fragment of C-type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas disease: role for neutral endopeptidase.
    Wang Y; Moreira Mda C; Heringer-Walther S; Schultheiss HP; Siems WE; Wessel N; Walther T
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):62-6. PubMed ID: 20090473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the aminopeptidase A have prognostic and diagnostic value in Chagas disease and other dilated cardiomyopathies?
    Wang Y; Moreira Mda C; Heringer-Walther S; Khan A; Schultheiss HP; Wessel N; Siems WE; Walther T
    J Cardiovasc Pharmacol; 2011 Oct; 58(4):374-9. PubMed ID: 21697726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
    Bredin F; Liska J; Franco-Cereceda A
    Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
    Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
    J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BNP and ANP as diagnostic and predictive markers in heart failure with left ventricular systolic dysfunction.
    Falcão LM; Pinto F; Ravara L; van Zwieten PA
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):121-9. PubMed ID: 15526247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of circulating levels of hepatocyte growth factor in patients with chagas' disease and idiopathic dilated cardiomyopathy.
    Wang Y; Moreira Mda C; Khan A; Heringer-Walther S; Schultheiss HP; Wessel N; Siems WE; Walther T
    Cardiology; 2012; 121(4):240-6. PubMed ID: 22555361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP.
    Wang Y; Moreira Mda C; Heringer-Walther S; Ebermann L; Schultheiss HP; Wessel N; Siems WE; Walther T
    J Card Fail; 2010 Feb; 16(2):157-63. PubMed ID: 20142028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenascin-C as predictor of left ventricular remodeling and mortality in patients with dilated cardiomyopathy.
    Sarli B; Topsakal R; Kaya EG; Akpek M; Lam YY; Kaya MG
    J Investig Med; 2013 Apr; 61(4):728-32. PubMed ID: 23429699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
    Limongelli G; Pacileo G; Ancona R; Eusebio G; D'Andrea A; Romano M; Di Salvo G; Rea A; Calabró P; Romano G; Maiello C; Calabró R
    Am J Cardiol; 2010 Mar; 105(5):716-20. PubMed ID: 20185022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in left ventricular diastolic stiffness induced by physical training in patients with dilated cardiomyopathy.
    Malfatto G; Branzi G; Osculati G; Valli P; Cuoccio P; Ciambellotti F; Parati G; Facchini M
    J Card Fail; 2009 May; 15(4):327-33. PubMed ID: 19398081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil/lymphocyte ratio is related to the severity of idiopathic dilated cardiomyopathy.
    Avci A; Alizade E; Fidan S; Yesin M; Guler Y; Kargin R; Esen AM
    Scand Cardiovasc J; 2014 Aug; 48(4):202-8. PubMed ID: 24912526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of circulating levels of stem cell growth factor beta (SCGF beta) in patients with Chagas' disease and idiopathic dilated cardiomyopathy.
    Wang Y; Khan A; Heringer-Walther S; Schultheiss HP; Moreira Mda C; Walther T
    Cytokine; 2013 Mar; 61(3):728-31. PubMed ID: 23357302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N; Onishi K; Sato A; Terasaki F; Tsukada B; Nozato T; Yamada T; Imanaka-Yoshida K; Yoshida T; Ito M; Hiroe M
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of C-type natriuretic peptide in patients with idiopathic left ventricular dysfunction.
    Del Ry S; Giannessi D; Maltinti M; Prontera C; Iervasi A; Colotti C; Emdin M; L'Abbate A; Neglia D
    Peptides; 2007 May; 28(5):1068-73. PubMed ID: 17428580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload.
    Kotby AA; Taman KH; Sedky HT; Habeeb NM; El-Hadidi ES; Yosseif HS
    J Paediatr Child Health; 2013 Jan; 49(1):43-7. PubMed ID: 23279037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.